Summary

Asia Pacific Interventional Neurology Devices Market is valued approximately at USD 500 million in 2023 and is anticipated to grow with a healthy growth rate of more than 8.09% over the forecast period 2024-2032. Interventional neurology devices are specialized tools used by neurologists and neurosurgeons for minimally invasive procedures targeting the brain, spinal cord, and associated blood vessels. These devices include neurovascular stents, embolic coils, catheters, embolization devices, neurothrombectomy devices, intracranial stents, neuroendovascular clipping devices, and flow diverters. They play a crucial role in treating conditions such as aneurysms, stroke, intracranial stenosis and other vascular abnormalities, offering advantages such as quicker recovery times and improved patient outcomes compared to traditional open surgeries. The growing emphasis on expanding access to interventional neurology procedures and devices in emerging markets is a major growth trend in the Asia Pacific Interventional Neurology Devices Market.

The regional market is expected to experience growth due to factors such as a surge in the prevalence of neurological diseases and increased acceptance of minimally invasive treatments. In addition, Asia Pacific has a rapidly aging population, with a significant increase in individuals susceptible to age-related neurological disorders like stroke, aneurysms, and dementia. According to The World Bank, in 2015 the total population aged 65 and above in Japan was 33,081,239 and in 2021 the number reached 36,068,144. Also, as per the World Population Aging 2019 report, in China, the population aged above 65 years or above is projected to reach 246.98 million by 2030 from 164.48 million in 2019. Accordingly, this growing population creates a substantial demand for interventional neurology devices for diagnosis and treatment. Moreover, increasing awareness among healthcare professionals and patients about the benefits of minimally invasive procedures is driving the adoption of interventional neurology devices are further leveraging various growth opportunities for the market over the forecast period. However, high cost of devices and stringent regulatory scenario is likely to stifle market growth between 2022 and 2032.

The key countries considered for the Asia Pacific Interventional Neurology Devices Market study includes China, India, Japan, South Korea, Australia and Rest of Asia Pacific. In 2023, China was the largest regional market because of rising aging population, increased government public health initiatives and educational campaigns, coupled with the increasing focus on minimally invasive procedures Along with this, regulatory bodies in China are developing frameworks for reimbursing interventional neurological procedures, which improves patient access to these potentially life-saving treatments. The Chinese government actively encourages and subsidizes the domestic production of interventional neurology devices. This fosters the growth of local manufacturers, offering potentially cost-effective alternatives to established brands and promoting self-reliance in the medical technology sector. Whereas, the market in India is expected to grow at the fastest rate over the forecast period.

Major market player included in this report are:
MicroPort Scientific Corporation
Terumo Corporation
Kaneka Corporation
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10

The detailed segments and sub-segment of the market are explained below:

By Product Type
Cerebral Balloon Angioplasty and Stenting Systems
Neurothrombectomy Devices
Aneurysm Coiling and Embolization Devices
Micro-catheters
Guidewires

By Application
Artery Stenosis
Ischemic Strokes
Brain Aneurysm
Vein Stenosis
Others

By Region:
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. Asia Pacific Interventional Neurology Devices Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. Asia Pacific Interventional Neurology Devices Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Product Type
2.3.2. By Application
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Asia Pacific Interventional Neurology Devices Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Asia Pacific Interventional Neurology Devices Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Asia Pacific Interventional Neurology Devices Market Size & Forecasts by Product Type 2022-2032
5.1. Cerebral Balloon Angioplasty and Stenting Systems
5.2. Neurothrombectomy Devices
5.3. Aneurysm Coiling and Embolization Devices
5.4. Micro-catheters
5.5. Guidewires
Chapter 6. Asia Pacific Interventional Neurology Devices Market Size & Forecasts by Application 2022-2032
6.1. Artery Stenosis
6.2. Ischemic Strokes
6.3. Brain Aneurysm
6.4. Vein Stenosis
6.5. Others
Chapter 7. Asia Pacific Interventional Neurology Devices Market Size & Forecasts by Country 2022-2032
7.1. China Interventional Neurology Devices Market
7.1.1. Product Type breakdown size & forecasts, 2022-2032
7.1.2. Application breakdown size & forecasts, 2022-2032
7.2. India Interventional Neurology Devices Market
7.3. Japan Interventional Neurology Devices Market
7.4. Australia Interventional Neurology Devices Market
7.5. South Korea Interventional Neurology Devices Market
7.6. Rest of Asia Pacific Interventional Neurology Devices Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. MicroPort Scientific Corporation
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Terumo Corporation
8.3.3. Kaneka Corporation
8.3.4. Company 4
8.3.5. Company 5
8.3.6. Company 6
8.3.7. Company 7
8.3.8. Company 8
8.3.9. Company 9
8.3.10. Company 10
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes